Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Obesity (Silver Spring, Md.)|November 28, 2015
Nanoformulated copper/zinc superoxide dismutase reduces adipose inflammation in obesityCurtis Perriotte-Olson, Nikhil Adi, Devika S Manickam, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|January 14, 2020
Nanoformulated SOD1 ameliorates the combined NASH and alcohol-associated liver disease partly via regulating CYP2E1 expression in adipose tissue and liverThiyagarajan Gopal, Narendra Kumar, Curtis Perriotte-Olson, et al.
The Journal of Nutritional Biochemistry|February 11, 2017
A combination of dietary N-3 fatty acids and a cyclooxygenase-1 inhibitor attenuates nonalcoholic fatty liver disease in miceViswanathan Saraswathi, Curtis Perriotte-Olson, Murali Ganesan, et al.
Lipids|November 14, 2008
Lipid and phospholipid profiling of biological samples using MALDI Fourier transform mass spectrometryS Mariccor A B Batoy, Sabine Borgmann, Karin Flick, et al.
Alcohol Research : Current Reviews|April 19, 2021
Natural Recovery by the Liver and Other Organs after Chronic Alcohol UsePaul G Thomes, Karuna Rasineni, Viswanathan Saraswathi, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|September 5, 2017
Nanoformulated copper/zinc superoxide dismutase exerts differential effects on glucose vs lipid homeostasis depending on the diet composition possibly via altered AMPK signalingGopalakrishnan Natarajan, Curtis Perriotte-Olson, Fatema Bhinderwala, et al.
Biochemical and Biophysical Research Communications|December 23, 2015
Nanoformulated copper/zinc superoxide dismutase attenuates vascular cell activation and aortic inflammation in obesityViswanathan Saraswathi, Murali Ganesan, Curtis Perriotte-Olson, et al.
Metabolism: Clinical and Experimental|August 31, 2013
Impact of hematopoietic cyclooxygenase-1 deficiency on obesity-linked adipose tissue inflammation and metabolic disorders in miceViswanathan Saraswathi, Christopher J Ramnanan, Anson W Wilks, et al.
The Journal of Clinical Investigation|August 26, 2011
Brain insulin action augments hepatic glycogen synthesis without suppressing glucose production or gluconeogenesis in dogsChristopher J Ramnanan, Viswanathan Saraswathi, Marta S Smith, et al.
Pageof 5